Shopping Cart
Remove All
Your shopping cart is currently empty
Lonodelestat (POL6014) is a potent, orally active, and selective peptide inhibitor of human neutrophil elastase (hNE).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $1,520 | Inquiry | Inquiry |
| Description | Lonodelestat (POL6014) is a potent, orally active, and selective peptide inhibitor of human neutrophil elastase (hNE). |
| In vivo | Lonodelestat (POL6014), when intranasally administered to HNE-treated mice, significantly attenuated the inflammatory responses associated with Acute Lung Injury (ALI)[1]. Administered at varying doses (0.1, 0.5, 2, and 10 mg/kg), Lonodelestat demonstrated a dose-dependent decrease in inflammatory markers, prominently reducing the presence of macrophages, epithelial cells, neutrophils, and lymphocytes in bronchoalveolar lavage (BAL). The optimal effect was observed at a dose of 2 mg/kg, achieving a significant reduction in neutrophils (65%, p<0.001), epithelial cells (68%, p<0.001), macrophages (33%, p<0.001), and lymphocytes (77%, p<0.001). The study utilized ten-week-old male C57BL/6j mice, with dosages ranging from 0.05 to 5 mg/kg. Administration took place intranasally 15 minutes prior to HNE exposure (30 UI), effectively mitigating ALI's inflammatory processes[1]. |
| Synonyms | POL6014 |
| Molecular Weight | 1478.755 |
| Formula | C71H111N15O19 |
| Cas No. | 906547-89-5 |
| Smiles | [H][C@@]12CCCN1C(=O)[C@@]1([H])CCCN1C(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@]1([H])CCCN1C(=O)[C@]1([H])CCCN1C(=O)[C@@]([H])(NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@]([H])(NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCCCCC)NC2=O)[C@@H](C)O)[C@@H](C)CC |
| Sequence Short | cyclo[ASIPPQKYPPNle(bu)ET] |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.